Potential of osteopontin in the management of epithelial ovarian cancer

Radiology and Oncology

Ivan Verdenik^3,4¹  Erik Skof^2²  Benjamin Hadzialjevic^1³  Katarina Cerne^1⁴ 

[1] Department of Gynaecology and Obstetrics, Ljubljana, Slovenia^4;Department of Gynaecology, Ljubljana, Slovenia^3;Department of Medical Oncology, Ljubljana, Slovenia^2;Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, Ljubljana, Slovenia^1

关键词: advanced ovarian cancer;    osteopontin;    serum;    ascites;   

DOI  :  10.2478/raon-2019-0003

学科分类：肿瘤学

来源: Onkoloski Institut Ljubljana / Institute of Oncology Ljubljana

【 摘 要 】

BackgroundOsteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN concentrations in the two body fluids.

【 授权许可】

Unknown